Glucotrack's Lokahi acquisition target: $53K cash, $8.1M H1 loss, going concern doubt

Glucotrack, Inc.

Lokahi had $53,186 cash and no revenue as of June 30, 2026; total assets $2.5M vs liabilities $9.2M.
H1 2026 net loss of $8.1M; R&D expense $1.86M, G&A $4.1M, interest expense $2.16M.
Accumulated deficit $8.8M; shareholders' equity deficit $6.7M as of June 30, 2026.
Independent auditor raised substantial doubt about Lokahi's ability to continue as a going concern.
Cash used in operations $3.6M for six months ended June 30, 2026; no committed financing source.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.